Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mariliv
- Development stage
- Unknown
- Lead developer
- Emcee Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
**Mariliv** is an Emcee Pharmaceuticals oral hepatoprotective product family rather than one chemically uniform drug. It includes drops, suspensions, a double-strength suspension, and tablets. Public product listings identify different ingredient compositions across the formulations, including silymarin with tricholine citrate in drops and suspension products, silymarin with tricholine citrate and sorbitol in Mariliv DS Suspension, and silymarin-containing tablet products. These formulations are marketed for supportive management of fatty liver disease and other liver or hepatobiliary disorders. ([1mg.com](https://www.1mg.com/drugs/mariliv-drop-519813))
- Brand names
- MarilivMariliv DS SuspensionMariliv DropsMariliv SuspensionMariliv Tablet
02
Targets
OATP1B1 (Organic anion transporting polypeptide 1B1)ABCB1 (P-glycoprotein)CYP3A4 (Cytochrome P450 3A4)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)
Beyond the preview
Go deeper on Mariliv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mariliv.